Susan ALTSCHULLER

Insider Reports History

Location
Somerville, MA
Signature
/s/ Chandra Adams, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan ALTSCHULLER:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. SVP AND CFO Common Stock (right to buy) 361,568 $1,923,542 $5.32 04 Feb 2022 Direct
ImmunoGen, Inc. SVP AND CFO Stock Option (Right to Buy) 123,750 $642,263 $5.19 14 Nov 2022 Direct
Mural Oncology plc Director Ordinary Shares 10,000 $32,071 $3.21 14 Aug 2024 Direct
Mural Oncology plc Director Stock Option (right to buy) 8,462 $28,348 $3.35 30 May 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Financial Officer Common Stock 0 $0 $41.18 01 Aug 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Financial Officer Restricted Stock Units 0 $0 $41.18 01 Aug 2024 Direct
Climb Bio, Inc. Chief Financial Officer Stock Option (Right to Buy) 142,500 06 Jan 2026 Direct
Cerevel Therapeutics Holdings, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 01 Aug 2024 Direct

Insider Reports Filed by Susan ALTSCHULLER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLYM Climb Bio, Inc. 06 Jan 2026 1 $0 4 Chief Financial Officer 08 Jan 2026, 16:05
CLYM Climb Bio, Inc. 01 Oct 2025 1 $0 4 Chief Financial Officer 01 Oct 2025, 17:52
CLYM Climb Bio, Inc. 01 Oct 2025 0 $0 3 Chief Financial Officer 01 Oct 2025, 17:49
MURA Mural Oncology plc 14 Aug 2024 1 +$32,071 4 Director 15 Aug 2024, 16:15
/report/000095017024090813-altschuller-susan-2024-08-01 Cerevel Therapeutics Holdings, Inc. 01 Aug 2024 3 $0 4 Chief Financial Officer 05 Aug 2024, 16:26
MURA Mural Oncology plc 30 May 2024 1 $0 4/A Director 05 Jun 2024, 16:08
MURA Mural Oncology plc 30 May 2024 1 +$28,348 4 Director 03 Jun 2024, 10:11
/report/000095017024006706-altschuller-susan-2024-01-19 Cerevel Therapeutics Holdings, Inc. 19 Jan 2024 1 $0 4 Chief Financial Officer 23 Jan 2024, 17:51
/report/000095017023072368-altschuller-susan-2023-12-19 Cerevel Therapeutics Holdings, Inc. 19 Dec 2023 3 -$571,972 4 Chief Financial Officer 21 Dec 2023, 20:12
MURA Mural Oncology plc 14 Dec 2023 1 $0 4 Director 18 Dec 2023, 16:30
MURA Mural Oncology plc 31 Oct 2023 0 $0 3 Director 07 Nov 2023, 16:38
/report/000095017023026503-altschuller-susan-2023-06-01 Cerevel Therapeutics Holdings, Inc. 01 Jun 2023 2 $0 4 Chief Financial Officer 05 Jun 2023, 20:15
/report/000089924323013339-altschuller-susan-2023-05-15 Cerevel Therapeutics Holdings, Inc. 15 May 2023 0 $0 3 Chief Financial Officer 19 May 2023, 16:15
/report/000141588922012991-altschuller-susan-2022-05-20 ImmunoGen, Inc. 20 May 2022 2 $0 4 SVP AND CFO 27 Dec 2022, 16:14
/report/000117911022000926-altschuller-susan-2022-02-04 ImmunoGen, Inc. 04 Feb 2022 1 +$1,923,542 4 SVP & Chief Financial Officer 08 Feb 2022, 16:27